Industry
Probiota Global 2022, 28-30 March, is the ideal place to gain the latest knowledge in the field of prebiotics, probiotics and the microbiome.
Axial Therapeutics has published the results of a Clinical Trial investigating a novel molecule for managing symptoms associated with autism.
Probiota 2022: connecting the business and science of the microbiome is back in Copenhagen from the 28th to the 30th March.
DreamTec Research Limited is a biotechnology company working on an oral Covid-19 vaccine that can break through global distribution bottlenecks.
Kaleido Biosciences is exploring the potential of the microbiome to treat disease and improve human health.
Bacthera in collaboration with Seres Therapeutics announced to manufacture SER-109, an investigational oral microbiome therapeutic to treat recurrent Clostridioides difficile infection (CDI).
The Microbiome Connect: Gut Therapeutics Summit returns face to face on the 7-8 December. Join the list today whilst tickets are still available and don't forget to use MP10 to…
20 years ago the world leading groups of experts FAO/WTO defined probiotics microorganisms in food and food supplements
New criteria for the probiotics of the future. We discussed it with Lorenzo Morelli (Catholic University of the Sacred Heart, Italy).
Dr. Christine Robin, the principal investigator at the Henri-Mondor Hospital (Creteil, France), said: “With all my team, we are glad to have recruited the first patient in MICROCARE.”
